4//SEC Filing
PERRI ROSE C 4
Accession 0001144204-09-059727
CIK 0001059784other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 3:42 PM ET
Size
8.6 KB
Accession
0001144204-09-059727
Insider Transaction Report
Form 4
PERRI ROSE C
DirectorCOO, CFO, Treas. & Secy.
Transactions
- Purchase
Common Stock
2009-11-16$0.51/sh+10,000$5,100→ 404,726 total
Holdings
- 1,451,246(indirect: By Estate of Mark Perri)
Common Stock
- 953,667(indirect: By GHI, Inc.)
Common Stock
- 953,667(indirect: By GHI, Inc.)
Common Stock
- 341,496(indirect: By EBI, Inc.)
Common Stock
Footnotes (4)
- [F1]This aggregate number of shares does not include 200,000 shares of common stock underlying stock options which survived the death of Mark Perri, who was the reporting person's brother.
- [F2]The reporting person may be deemed to beneficially own such 341,496 shares owed of record by EBI, Inc. because the reporting person holds the right to vote such shares.
- [F3]The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. by reason of the reporting person's ownership of investment power and other economic benefits associated with such shares.
- [F4]The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. because the reporting person holds the right to vote such shares.
Documents
Issuer
GENEREX BIOTECHNOLOGY CORP
CIK 0001059784
Entity typeother
Related Parties
1- filerCIK 0001125858
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 3:42 PM ET
- Size
- 8.6 KB